Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2011 | |
| Cash Flows From Operating Activities | |
| Other Working Capital | 56 |
| Other Operating Activity | -88 |
| Operating Cash Flow | $-33 |
| Cash Flows From Investing Activities | |
| PPE Investments | -16 |
| Other Investing Activity | -424 |
| Investing Cash Flow | $-440 |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 794 |
| Other Financing Activity | -77 |
| Financing Cash Flow | $717 |
| End Cash Position | 244 |
| Net Cash Flow | $244 |
| Free Cash Flow | |
| Operating Cash Flow | -33 |
| Capital Expenditure | -16 |
| Free Cash Flow | -49 |